2BBBullish & Bearish
Health Care

Climb Bio, Inc. (CLYM) Stock Score & Signals

Climb Bio, Inc. (CLYM) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 38 out of 100.

2BB score and signals

Climb Bio, Inc.’s current 2BB score is 38 out of 100, built from the signal categories below.

SignalScoreReading
Activity71High
Momentum61Improving
Financial strength42Normal
Quality64Strong
Risk50Moderate

Company facts

HeadquartersWellesley Hills, Massachusetts, United States
Founded2018
Employees29
52-week range$1.64 – $18.33

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2026-08-18—-0.2208—$0.00
2026-05-07-0.2-0.272$0.00$0.00
2026-03-05-0.26-0.2009$0.00$0.00